New HIV vaccine strategy “pumps” the immune system
LA JOLLA, CA – A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical
Imagine Life Without Disease
Every day, all of us here at LJI work toward Life Without Disease. The challenges we face are neither small
Q&A with Sujan Shresta
Thanks to climate change, very little now stands in the way of dengue and Zika virus continuing to spread outside
Data don’t scare ’em
The contents of the Immune Epitope Database (IEDB) are shocking. The free, searchable site is home to data from more
Researcher Studying Potential Trigger of Inflammation Through VF-Funded Grant
Dr. Mitchell Kronenberg elected Distinguished Fellow by the American Association of Immunologists
LA JOLLA, CA—The American Association of Immunologists (AAI) has named La Jolla Institute for Immunology (LJI) President and Chief Scientific
TET gene mutations in T regulatory cells unleash fatal autoimmune disease in mice
LA JOLLA, CA—A subtype of T cells called T regulatory cells are major players in two front-page health issues: autoimmune
LJI investigators reveal that TET proteins regulate factors essential for normal antibody production
LA JOLLA, CA—A family of TET proteins regulates gene expression in many cell types by influencing chromosome structure. TET proteins
To respond or tolerate? LJI researchers selectively block immune activation program orchestrated by the nuclear factor NFAT
LA JOLLA, CA—The immune system occasionally makes mistakes that require correction. For example, in autoimmunity, T-cells lose “immune tolerance” of
Chan Zuckerberg Initiative names La Jolla Institute bioengineer “Imaging Scientist”
LA JOLLA, CA—Sara McArdle, Ph.D., a microscopy specialist at La Jolla Institute for Immunology (LJI), has been selected as one
Scientists devise strategies to counteract T cell exhaustion in CAR T cancer therapies
LA JOLLA, CA – A growing number of cancer patients are being offered a promising new treatment called CAR T